Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882812PMC
http://dx.doi.org/10.1038/s41408-019-0259-8DOI Listing

Publication Analysis

Top Keywords

repurposing auranofin
4
auranofin treat
4
treat tp53-mutated
4
tp53-mutated pten-deleted
4
pten-deleted refractory
4
refractory b-cell
4
b-cell lymphoma
4
repurposing
1
treat
1
tp53-mutated
1

Similar Publications

Human fungal infections comprise systemic mycoses as well as various skin diseases. Rising case numbers along with inefficient therapies and the appearance of drug-resistant strains unleashed a considerable health problem over the last years. Thus, the identification and development of new antifungal drugs is mandatory, which can include the design of new antifungals, or, more time saving, the repurposing of known drugs already applied for the therapy of other human diseases.

View Article and Find Full Text PDF

Unlabelled: Hepatitis E virus (HEV) causes roughly 20 million yearly global infections, and is associated with chronic hepatitis, neurological sequelae and pregnancy-related adverse outcomes that require antiviral therapeutic intervention. While there are currently no approved HEV-specific therapeutics, ribavirin and pegylated interferon, prescribed off-label, are the current standard of care. However, ribavirin resistance and toxicity highlight the unmet clinical need to identify safer, HEV-specific antivirals.

View Article and Find Full Text PDF

Background: Variants of SORL1 have been associated with both late and early onset of Alzheimer's disease (AD). SORL1 encodes the sorting-related receptor with A repeat (SORLA) protein, which belongs to the VPS10 receptor family. SORLA protects against AD pathogenesis through its sorting function, and reduced SORLA levels have been consistently observed in sporadic AD.

View Article and Find Full Text PDF

Synergistic Antifungal Activity of Pentamidine and Auranofin Against Multidrug-Resistant Candida auris.

Mycopathologia

May 2025

Health Sciences Research Laboratory, Universidade Federal of Grande Dourados, Rodovia Dourados - Itahum km 12, Cidade Universitária, Dourados, Mato Grosso do Sul, CEP: 79804970, Brazil.

Background: Candida auris is a significant clinical concern due to its ability to cause outbreaks in healthcare settings and its common resistance to current treatments. This highlights the need for alternative therapies. Drug repurposing offers a promising approach, and the combination of pentamidine (antiprotozoal) and auranofin (anti-rheumatic) has shown potential antifungal activity against Candida species, including C.

View Article and Find Full Text PDF

The gold complex auranofin sensitizes platinum resistant epithelial ovarian cancer cells to cisplatin.

Biochem Biophys Rep

June 2025

Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, H3A 2B4, Canada.

Although numerous drugs have been tested to treat ovarian cancer (OC), survival rates remain low as there has been no major improvement from platinum (Pt)-based therapy and there is a high rate of Pt resistance in these tumors. Following several rounds of chemotherapy, OC cells develop Pt-resistance by increasing DNA repair and antioxidant defense mechanisms. This study aimed to design a treatment to combat recurrent stages of OC by repurposing the anti-rheumatic gold complex auranofin (AF).

View Article and Find Full Text PDF